Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Novavax, Inc. (NVAX) Starts Presentation at 25th Annual ROTH Conference

Posted on March 19, 2013 by Mission IR

Novavax is a clinical-stage biopharmaceutical company using innovative recombinant protein nanoparticle vaccine technology, as well as new and efficient manufacturing vaccines to address a broad range of infectious diseases worldwide. NVAX is involved in several international partnerships, including collaborations with Cadila Pharmaceuticals of India, LG Life Sciences of Korea, and PATH. For more information, visit the company’s Web site: http://www.novavax.com

Let us hear your thoughts below:

This year's annual ROTH Conference will take place at The Ritz Carlton located in Laguna Niguel, on March 17-12, 2013. Bringing together executives from more than 400 growth companies, the ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com.
This entry was posted in ROTH Capital Partners Conference. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *